Profile
ALIM ZTS TAK HLN TEVA NBIX
Company Name Alimera Sciences, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $301.29M $63.86B $42.85B $42.64B $28.05B $15.29B
Employees 0.15K 13.80K 49.28K 24.56K 37.00K 1.80K
CEO Richard S. Eiswirth Jr. Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Kyle W. Gano
Ratings
ALIM ZTS TAK HLN TEVA NBIX
Quant Rating Score 1 3 3 3 3 4
Quant Rating Strong Sell Neutral Neutral Neutral Neutral Buy
Trading
ALIM ZTS TAK HLN TEVA NBIX
Last Close $5.54 $119.56 $13.64 $9.41 $24.46 $154.8
High 52 $5.54 $178.71 $15.52 $11.41 $24.6 $154.8
Low 52 $5.54 $119.56 $12.89 $8.73 $12.82 $87.59
Price vs. 52 Week High 0 % -33.1 % -12.11 % -17.53 % -0.57 % 0 %
Price vs. 52 Week Low 0 % 0 % 5.82 % 7.79 % 90.8 % 76.73 %
Total Return
ALIM ZTS TAK HLN TEVA NBIX
1 Month Return 0 % -16.26 % -5.64 % 6.69 % 21.87 % 12.99 %
3 Month Return 0 % -19.32 % -5.05 % -0.58 % 50.15 % 23.21 %
6 Month Return 0 % -23.31 % -9.43 % -12.59 % 38.98 % 27.23 %
9 Month Return 0 % -30.26 % 0.81 % -1.47 % 45.16 % 26.89 %
YTD Return 0 % -26.62 % 3.02 % -1.36 % 10.98 % 13.41 %
1 Year Return 0 % -31.39 % -1.59 % -1.98 % 39.77 % 24.86 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALIM ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.34 % 4.72 % 1.57 % - -
Dividend Paid and Capex Coverage Ration (TTM) -0.19 % 1.89 % 2.01 % 2.01 % 2.78 % 14.57 %
Dividend Per Share (TTM) - 1.93 % 198 % 0.06 % - -
Payout Ratio (TTM) -6.25 % 32.08 % 226.17 % 27.27 % - -
Profitability
ALIM ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 75.75 % 70.03 % 52.77 % 61.81 % 49.6 % 98.37 %
Return on Assets TTM -13.11 % 18.04 % 0.98 % 4.78 % -0.39 % 10.03 %
Return on Equity TTM -159.01 % 53.21 % 1.95 % 9.4 % -2.58 % 15.82 %
Return on Capital Employed TTM -1.47 % 31.67 % 4.8 % 8.34 % 3.16 % 15.17 %
Net Income Per EBT TTM 100.42 % 78.72 % 72.4 % 76.52 % 222.54 % 68.09 %
EBT Per Ebit TTM 1037.63 % 94.26 % 33.29 % 88.09 % -7.94 % 114.25 %
EBIT Per Revenue TTM -2.39 % 37.51 % 12.68 % 20.49 % 5.38 % 20.51 %
Cash Flow To Debt Ratio TTM -21.16 % 43.13 % 22.35 % 12.02 % 7.93 % 148.65 %
Receivables Turnover TTM 2.34 6.09 6.59 5.14 4.67 3.69
Payables Turnover TTM 2.37 5.54 5.02 1.18 3.35 0.37
Inventory Turnover TTM 10.42 1.15 1.71 3.72 2.4 0.63
Fixed Asset Turnover TTM 2249.42 % 244.46 % 229.02 % 589.57 % 321.73 % 473.81 %
Asset Turnover TTM 52.6 % 64.82 % 31.99 % 34.62 % 41.43 % 62.89 %
Operating Cash Flow Per Share TTM -0.56 6.58 643.53 0.11 1.21 6.41
Free Cash Flow Per Share TTM -3.51 4.99 521.29 0.1 0.78 5.97
Cash Per Share TTM 47.3 % 322.4 % 22368.59 % 7.46 % 188.4 % 1121.53 %
Operating Cash Flow Sales Ratio TTM -17.66 % 31.21 % 22.48 % 9.32 % 8.36 % 23.74 %
Free Cash Flow Operating Cash Flow Ratio TTM 629.64 % 75.76 % 81.01 % 90.65 % 64.03 % 93.14 %
Cash Flow Coverage Ratios TTM -21.16 % 43.13 % 22.35 % 12.02 % 7.93 % 148.65 %
Price To Free Cash Flows Ratio TTM -3.36 28.78 8.1 34.18 31.29 25.77
Price To Operating Cash Flows Ratio TTM -9.93 21.9 6.51 31.51 20.03 24
Price Cash Flow Ratio TTM -9.93 21.9 6.51 31.51 20.03 24
Income Statement (TTM)
ALIM ZTS TAK HLN TEVA NBIX
Revenue $0.08B $9.26B $4581.55B $11.23B $16.54B $2.36B
Gross Profit $0.06B $6.4B $3001.33B $6.95B $8.06B $2.32B
Gross Profit Ratio 75.75% 69.1% 65.51% 61.85% 48.74% 98.56%
EBITDA $-0B $3.87B $1210.51B $2.51B $0.78B $0.64B
Net Income $-0.02B $2.49B $107.93B $1.44B $-1.64B $0.34B
EPS Diluted -0.79 5.47 33.62 0.32 -1.45 3.29
Balance Sheet (MRQ)
ALIM ZTS TAK HLN TEVA NBIX
Long Term Debt $0.06B $5.39B $4517.23B $8.62B $16.3B $0.46B
Total Liabilities $0.11B $9.47B $7312.37B $18.09B $33.61B $1.13B
Total Equity $0.05B $4.77B $6935.98B $16.22B $5.72B $2.59B
Total Investments $0B $0.03B $382.4B $0.08B $0B $1.71B
Total Debt $0.07B $6.74B $5066.17B $10.1B $18.08B $0.46B
Total Assets $0.15B $14.24B $14248.34B $34.32B $39.33B $3.72B
Cash Flow Statement (TTM)
ALIM ZTS TAK HLN TEVA NBIX
Net Income $-0.02B $2.5B $107.93B $1.44B $-1.96B $0.34B
Inventory $-0B $-0.04B $-34.97B $0.22B $0.17B $-0.02B
Dividends Paid $-0B $-0.79B $-302.5B $-0.57B $0B $0B
Operating Cash Flow $-0.01B $2.95B $1057.18B $2.3B $1.25B $0.6B
Capital Expenditure $-0.08B $-0.66B $-200.8B $-0.25B $-0.5B $-0.04B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.555
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.315
ALVO Alvotech 5.705
ALVOW Alvotech 0.78
AMPH Amphastar Pharmaceuticals, Inc. 24.04
AMRX Amneal Pharmaceuticals, Inc. 11.37
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 90.49
APUS Apimeds Pharmaceuticals US, Inc 2.2899
AQST Aquestive Therapeutics, Inc. 6.045
ASRT Assertio Holdings, Inc. 0.7609
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 18.7
AYTU Aytu BioPharma, Inc. 2.03
ETFs With Exposure to ALIM
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00462 241.61
VTI Vanguard Total Stock Market Index Fund 0 330.12
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 146.48
IWN iShares Russell 2000 Value ETF 0.00105 175.795
IWO iShares Russell 2000 Growth ETF 0.00841 321.06
VXF Vanguard Extended Market Index Fund 0 207.9
HDG ProShares Hedge Replication ETF 0.000735944 51.435
UWM ProShares Ultra Russell2000 0.00175936 45.745
VTHR Vanguard Russell 3000 Index Fund 0 295.86
IWC iShares Micro-Cap ETF 0.03229 149.3
URTY ProShares UltraPro Russell2000 0.000866593 51.42
VTWV Vanguard Russell 2000 Value Index Fund 0 154.915
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 234.345
VTWO Vanguard Russell 2000 Index Fund 0 97.69
DFUS Dimensional U.S. Equity ETF 0 72.9
DFAC Dimensional U.S. Core Equity 2 ETF 0 38.625
VTSAX Vanguard Total Stock Market Index Fund 0 160.27
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 156.17
VITSX Vanguard Total Stock Market Index Fund 0 160.3
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 156.18
VEMPX Vanguard Extended Market Index InstlPlus 0 385.39
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 300.71
RSSL Global X Funds 0.01 94
Unlock